JP2022060295A5 - - Google Patents

Download PDF

Info

Publication number
JP2022060295A5
JP2022060295A5 JP2022017469A JP2022017469A JP2022060295A5 JP 2022060295 A5 JP2022060295 A5 JP 2022060295A5 JP 2022017469 A JP2022017469 A JP 2022017469A JP 2022017469 A JP2022017469 A JP 2022017469A JP 2022060295 A5 JP2022060295 A5 JP 2022060295A5
Authority
JP
Japan
Prior art keywords
invention described
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2022017469A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022060295A (ja
Filing date
Publication date
Priority claimed from JP2021571463A external-priority patent/JP7022873B1/ja
Application filed filed Critical
Publication of JP2022060295A publication Critical patent/JP2022060295A/ja
Publication of JP2022060295A5 publication Critical patent/JP2022060295A5/ja
Priority to JP2026034432A priority Critical patent/JP2026074401A/ja
Ceased legal-status Critical Current

Links

JP2022017469A 2020-07-22 2022-02-07 アリールアミド誘導体を含む組成物 Ceased JP2022060295A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2026034432A JP2026074401A (ja) 2020-07-22 2026-03-04 アリールアミド誘導体を含む組成物

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2020125822 2020-07-22
JP2020125822 2020-07-22
JP2021571463A JP7022873B1 (ja) 2020-07-22 2021-07-21 アリールアミド誘導体を含む組成物
PCT/JP2021/027316 WO2022019329A1 (ja) 2020-07-22 2021-07-21 アリールアミド誘導体を含む組成物

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2021571463A Division JP7022873B1 (ja) 2020-07-22 2021-07-21 アリールアミド誘導体を含む組成物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2026034432A Division JP2026074401A (ja) 2020-07-22 2026-03-04 アリールアミド誘導体を含む組成物

Publications (2)

Publication Number Publication Date
JP2022060295A JP2022060295A (ja) 2022-04-14
JP2022060295A5 true JP2022060295A5 (cg-RX-API-DMAC7.html) 2024-07-31

Family

ID=79729189

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2021571463A Active JP7022873B1 (ja) 2020-07-22 2021-07-21 アリールアミド誘導体を含む組成物
JP2022017469A Ceased JP2022060295A (ja) 2020-07-22 2022-02-07 アリールアミド誘導体を含む組成物
JP2026034432A Pending JP2026074401A (ja) 2020-07-22 2026-03-04 アリールアミド誘導体を含む組成物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2021571463A Active JP7022873B1 (ja) 2020-07-22 2021-07-21 アリールアミド誘導体を含む組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2026034432A Pending JP2026074401A (ja) 2020-07-22 2026-03-04 アリールアミド誘導体を含む組成物

Country Status (16)

Country Link
US (1) US20230270730A1 (cg-RX-API-DMAC7.html)
EP (1) EP4186506A4 (cg-RX-API-DMAC7.html)
JP (3) JP7022873B1 (cg-RX-API-DMAC7.html)
KR (2) KR20230122174A (cg-RX-API-DMAC7.html)
CN (1) CN115803024B (cg-RX-API-DMAC7.html)
AU (1) AU2021311665A1 (cg-RX-API-DMAC7.html)
BR (1) BR112023000883A2 (cg-RX-API-DMAC7.html)
CA (1) CA3186655A1 (cg-RX-API-DMAC7.html)
CL (1) CL2023000199A1 (cg-RX-API-DMAC7.html)
CR (1) CR20230095A (cg-RX-API-DMAC7.html)
IL (1) IL300051B1 (cg-RX-API-DMAC7.html)
MX (1) MX2023000857A (cg-RX-API-DMAC7.html)
PE (1) PE20231094A1 (cg-RX-API-DMAC7.html)
TW (1) TWI904197B (cg-RX-API-DMAC7.html)
WO (1) WO2022019329A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202302083B (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115151533B (zh) 2020-01-10 2025-08-08 医疗免疫工程公司 Mek抑制剂及其治疗用途
AR121078A1 (es) 2020-01-22 2022-04-13 Chugai Pharmaceutical Co Ltd Derivados de arilamida con actividad antitumoral
WO2022018875A1 (ja) * 2020-07-22 2022-01-27 中外製薬株式会社 アリールアミド誘導体を含む細胞増殖性疾患の治療又は予防用医薬組成物
KR20230122174A (ko) * 2020-07-22 2023-08-22 추가이 세이야쿠 가부시키가이샤 아릴 아마이드 유도체를 포함하는 조성물
CN117642166A (zh) * 2021-06-09 2024-03-01 中外制药株式会社 用于癌症治疗的组合疗法
AU2022312992A1 (en) * 2021-07-21 2024-02-29 Chugai Seiyaku Kabushiki Kaisha Method for producing arylamide derivative
WO2023204259A1 (ja) * 2022-04-20 2023-10-26 中外製薬株式会社 がんの治療又は予防用医薬
CN119421874A (zh) * 2022-06-30 2025-02-11 上海喆邺生物科技有限公司 一种芳香酰胺类衍生物及其在抗肿瘤药物中的应用
EP4551558A2 (en) * 2022-07-08 2025-05-14 Nested Therapeutics, Inc. Mitogen-activated protein kinase (mek) inhibitors
WO2025063275A1 (ja) * 2023-09-21 2025-03-27 中外製薬株式会社 アリールアミド誘導体の製造方法
AU2024417154A1 (en) * 2024-01-01 2026-08-13 Huajian Future (Chengdu) Technology Co., Ltd. Aromatic hydrazide derivative and medical use thereof
CN119912402B (zh) * 2024-02-07 2025-11-28 中国科学院上海药物研究所 Fto抑制剂及其制备方法和应用
WO2026098657A1 (zh) * 2024-11-08 2026-05-15 先声再明医药股份有限公司 作为mek抑制剂的杂环化合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4931419B2 (ja) * 2003-09-19 2012-05-16 中外製薬株式会社 新規4−フェニルアミノ−ベンズアルドオキシム誘導体並びにそのmek阻害剤としての使用
KR101190912B1 (ko) * 2003-11-19 2012-10-12 어레이 바이오파마 인크. Mek의 헤테로시클릭 억제제 및 그의 사용 방법
US7732616B2 (en) * 2003-11-19 2010-06-08 Array Biopharma Inc. Dihydropyridine and dihydropyridazine derivatives as inhibitors of MEK and methods of use thereof
MY144232A (en) * 2004-07-26 2011-08-15 Chugai Pharmaceutical Co Ltd 5-substituted-2-phenylamino benzamides as mek inhibitors
AR059339A1 (es) 2006-02-09 2008-03-26 Chugai Pharmaceutical Co Ltd Derivados de la cumarina para trastornos proliferativos de celulas, composicion farmaceutica y agente terapeutico que los contiene
CN102574782B (zh) * 2009-10-21 2014-10-08 拜耳知识产权有限责任公司 取代的卤代苯氧基苯甲酰胺衍生物
AR121078A1 (es) * 2020-01-22 2022-04-13 Chugai Pharmaceutical Co Ltd Derivados de arilamida con actividad antitumoral
KR20230122174A (ko) * 2020-07-22 2023-08-22 추가이 세이야쿠 가부시키가이샤 아릴 아마이드 유도체를 포함하는 조성물
CN117642166A (zh) * 2021-06-09 2024-03-01 中外制药株式会社 用于癌症治疗的组合疗法

Similar Documents

Publication Publication Date Title
JP2022068302A5 (cg-RX-API-DMAC7.html)
JP2024023385A5 (cg-RX-API-DMAC7.html)
JP2022028828A5 (cg-RX-API-DMAC7.html)
JP2022025124A5 (cg-RX-API-DMAC7.html)
JP2021185136A5 (cg-RX-API-DMAC7.html)
JP2021169491A5 (cg-RX-API-DMAC7.html)
JP2024059739A5 (cg-RX-API-DMAC7.html)
JP2023022224A5 (cg-RX-API-DMAC7.html)
JP2023116721A5 (cg-RX-API-DMAC7.html)
JP2024016014A5 (cg-RX-API-DMAC7.html)
JP2021038271A5 (cg-RX-API-DMAC7.html)
JP2025506484A5 (cg-RX-API-DMAC7.html)
JP2023100643A5 (cg-RX-API-DMAC7.html)
JP2020171301A5 (cg-RX-API-DMAC7.html)
JP2020120660A5 (cg-RX-API-DMAC7.html)
JP2024112817A5 (cg-RX-API-DMAC7.html)
JP2023011759A5 (cg-RX-API-DMAC7.html)
JP2025084837A5 (cg-RX-API-DMAC7.html)
JP2022537813A5 (cg-RX-API-DMAC7.html)
JP2023085551A5 (cg-RX-API-DMAC7.html)
JP2024534771A5 (cg-RX-API-DMAC7.html)
JP2020141705A5 (cg-RX-API-DMAC7.html)
JP2022022379A5 (cg-RX-API-DMAC7.html)
JP2024063214A5 (cg-RX-API-DMAC7.html)
JP2022122912A5 (cg-RX-API-DMAC7.html)